ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

APYX vs PYPD // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Apyx Medical Corporation (NASDAQ) VS. PolyPid Ltd. (NASDAQ) • 15-METRIC TALLY: APYX 3 — PYPD 2
■ METRIC PARITY
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (APYX VS. PYPD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC APYX PYPD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 62.50% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -28.90% -35.00% +6.10 APYX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -8.04% -24.74% +16.70 APYX /fcf-yield <GO>
Operating Margin -12.20% — — TIE /operating-margins <GO>
Net Profit Margin -21.20% — — TIE /net-margins <GO>
Revenue Growth (YoY) 9.90% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.75 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 2/9 +3.00 APYX /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.1 59.3 -10.15 PYPD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $113.3M $113.5M -$229.2K PYPD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR APYX REV PYPD REV APYX GROSS % PYPD GROSS % APYX FCF PYPD FCF
FY 2025 $52.8M $0 62.5% — -$9.1M -$28.1M
FY 2024 $48.1M $0 61.0% — -$18.8M -$22.0M
FY 2023 $52.3M $0 — — -$5.2M -$17.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
APYX // BETA —
PYPD // BETA —